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In vitro Evaluation of the Antiviral Activity of an Extract of Date
Palm (Phoenix dactylifera L.) Pits on a Pseudomonas Phage
Sabah A. A. Jassim and Mazen A. Naji
Department of Microbiology, Zayed Complex for Herbal Research and Traditional Medicine, General Authority for
Health Services for the Emirate of Abu Dhabi
A crude acetone extract of the pit of date palm (Phoenix dactylifera L.) was prepared and
its antiviral activity evaluated against lytic Pseudomonas phage ATCC 14209-B1, using
Pseudomonas aeruginosa ATCC 25668 as the host cell. The antiviral activity of date pits was
found to be mediated by binding to the phage, with minimum inhibitory concentration (MIC)
of < 10mgm l
1. The decimal reduction time (D-values), the concentration exponent (Z) and the
phage inactivation kinetics were determined. The date pit extracts show a strong ability to
inhibit the infectivity of Pseudomonas phage ATCC 14209-B1 and completely prevented
bacterial lysis, which it is hoped will promote research into its potential as a novel antiviral
agent against pathogenic human viruses.
Keywords: antiviral–bacteriophage–CAM–MIC–phage–Phoenix dactylifera L.–
Pseudomonas aeruginosa
Introduction
The pits or seeds of many fruit are used in complemen-
tary and alternative medicine (CAM) in an effort to
prevent illness, reduces stress, prevent or reduce side
effects and symptoms, or control or cure disease.
The Mexican people traditionally used crushed apricot
pits to treat cancer (https://www.dana-farber.org/can/
supportive-care/View.aspx?lang=en&audience=0&doc=
CDR0000446369) and also in Russia as early as 1845
(http://www.alternativehealth-uk.com/freeadvice.htm)
and recently the patented version called Laetrile a semi-
synthetic compound form of amygdalin (found in the
pits of many fruits mainly in apricot pits, in raw nuts,
and in other plants) is used for cancer treatment in
humans worldwide (http://cancerweb.ncl.ac.uk/cancernet/
600093.html). On the other hand, the grape seed with
antiviral activity (SAA Jassim, unpublished data) has
been used as a dietary source of essential fatty acids and
tocopherols and as an antioxidant, for liver protective
effects, to improve circulation (including conditions such
as varicose veins, bruising, swelling, and decreased
vision), and to improve skin tone and elasticity (http://
www.drugs.com/mtm/grape-seed.html). Whilst, the grape-
fruit seed extract (GSE) used to treat a major therapeutic
breakthrough for patients with chronic parasitic and
yeast infections (1). The latter authors also examined the
effect of GSE on 770 strains of bacteria and 93 strains of
fungus and compared this with 30 effective antibiotics
and 18 proven fungicides. GSE was found to perform as
well as any and all of the tested agents. Furthermore, the
seed oil of both Nigella sativa and Neem has been used
traditionally in Asia and Middle East to treat many
diseases (2) and several viral diseases (3, http://www.pet
zlife.co.uk/gse.html). Interestingly a form of pokeweed
antiviral protein has been isolated from the seeds of
Phytolacca americana (4) while the ribosome-inactivating
proteins has been isolated from the seeds of Saponara
officinalis L. (soapwort), of Agrostemma githago L. (corn
cockle) and of Asparagus officinalis L. (asparagus), and
from the latex of Hura crepitans (5). In contrast, the seeds
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properly cited.of Momordica charantia, a bitter melon fruit that is
widely used as food as well as medicine in Asia,
has a particular clinical usefulness similar to MAP30
(Momordica anti-HIV protein; molecular weight: 30kDa)
is believed to have multiple functions that could be
beneficial for HIV (3).
Still viral diseases, including emerging and established
viruses, are an increasing worldwide health concern.
However, the search for antiviral compounds has not
been easy and relatively few antiviral drugs are available,
while those approved for use often have bad side-effect
profiles and are able to cause rapid resistance among
targeted viral strains (6). Asaconsequence, the discovery of
new antiviral agents from a variety of sources, including
plants, has assumed more urgency than in the past (3).
It is essential, therefore, to continue the search for useful
and novel natural antiviral agents, which can be expected
to prolong the efficacy of drug therapy in subjects infected
with HIV. For this reasons the date palm (Phoenix
dactylifera L.) is widely used for some traditional medicines
(http://en.wikipedia.org/wiki/Phoenix_dactylifera#
Traditional_medicinal_uses) in many parts in the Middle
East and because it is the main subject in this study,
therefore it has been discussed further for their uses in the
CAM and antimicrobial activities.
The Phoenix dactylifera L. is a monocotyledoneus
woody perennial belonging to the Arecaceae family,
which comprises 200 genera and 3000 species (7). The
beneficial health and nutrition values of date palm
(Phoenix dactylifera L.), for human and animal con-
sumption, have been claimed for centuries (8).
The date pits, also called pips, stones, kernels or seeds,
form part of the integral date fruit. Depending on variety
and grade quality, the pits represent about 6–12% of
the total weight of the mature date (8). The seed powder is
also used in some traditional medicines (http://en.wikipe
dia.org/wiki/Phoenix_dactylifera#Traditional_medicinal_
uses) and has been investigated for human potential health
benefits (9), and for addition to animal feed to enhance
growth (10–13), the latter an action that has been ascribed
to an increase in the plasma level of estrogens (14) or
testosterone (15). Date pits have been studied as potential
sources of edible oils and pharmaceuticals (16). In addition,
date pit extract shows an ability to restore the normal
functional status of the poisoned liver, and also to protect
against subsequent carbon tetrachloride hepatotoxicity on
the liver in rats (17).
In terms of dry weight, the chemical composition
of date pits has been reported as containing 5–10%
moisture, 5–7% protein, 7–10% oil, 10–20% crude fiber,
55–65% carbohydrates and 1–2% ash (8,16). The carbo-
hydrates, as the largest component of the dry weight, are
typically comprised of neutral detergent fiber 75%, acid
detergent fiber 57.5%, hemicelluloses 17.5%, lignin 11%,
cellulose 42.5% and ash 4% (8,9).
Furthermore, the utilization of date pits in the produc-
tion of citric acid and protein by Candida lipolytica,
Apergillus oryzae and Candida utilis were also investi-
gated (respectively, 18–20). However, the antimicrobial
activity of date pits has been poorly investigated (9), and
only an ethanolic extract of date pits has been used and
this only showed a weak antimicrobial activity on several
strains of microorganisms (21). The evidence of the date
pits that can be used as CAM to treat human viral
diseases are based on a hypothesis is discussed in present
study.
Materials and Methods
Media
Luria broth (LB): tryptone 10gl
1 (HiMedia, Mumbai,
India), yeast extract 5gl
1 (HiMedia, Mumbai, India),
and sodium chloride 10gl
1 (HiMedia, Mumbai, India)
at pH 7.2 were used in all the protocols. L-agar (LA),
consisted of the above with the addition of 14gl
1 agar
(HiMedia, Mumbai, India) was used for culture main-
tenance. Bacterial dilutions from 18h LB cultures grown
at 37C were carried out in phosphate buffered saline
(PBS, Oxoid, England). For plaque assay, the ‘soft layer
agar’ used was LB prepared in Lambda-buffer
[6mmoll
1 Tris pH 7.2, 10mmol l
1Mg(SO4)2.7H2O,
50mgm l
1 gelatin (Oxoid, England)], was supplemented
with 4g l
1 agar bacteriology No. 1 (HiMedia, Mumbai,
India).
Bacterial Strain
Pseudomonas aeruginosa ATCC 25668 was used through-
out the study. Cultures were stored at 20C in 15%
glycerol (22). Prior to investigation a stock culture of the
bacteria was maintained on LA plate. One loopful of the
P. aeruginosa was inoculated into a 100ml Erlenmeyer
flask containing 10ml of LB and incubated for 18h at
37C and 90revmin
1 in an incubator shaker (Innova
4000, New Brunswick Scientific). For experimental tests
appropriate serial dilutions were made in LB.
Bacteriophage
A lytic Pseudomonas phage ATCC 14209-B1 was used
in this study. The phage stocks were prepared on the
host strain, P. aeruginosa ATCC 25668, by a plate lysis
procedure essentially equivalent to growing bacteriophage
Lambda-derived vectors (23). Briefly, the method for the
preparation of a large volume of Pseudomonas phage
ATCC 14209-B1 by the soft layer plaque technique was
as follows: An aliquot (100ml) of the phage sample
(10-fold serially diluted with Lambda-buffer) was mixed
with 100ml of an overnight LB culture of P. aeruginosa
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tube (polypropylene; 1.5ml; Sarstedt) and incubated for
15min at 37C to facilitate attachment of the phage to
the host cells. The mixture was transferred from the
Eppendorf micro-centrifuge tube to a 5ml Bijou bottle
and then 2.3ml of soft layer agar was added which had
been melted and cooled to 40C in a water bath. The
contents of each bottle were then well mixed by swirling,
poured over the surface of a plate of LA and allowed to
set for 15min at room temperature. The plates were
incubated for 18h at 37C, and a plate showing almost
confluent plaques was used to prepare a concentrated
phage suspension by overlaying with 5ml of Lambda-
buffer [titre 10
12 plaque-forming units per ml (pfu ml
1)].
The final purification process used chloroform to
separate the bacteriophage from the bacterial cells (23).
The phage stocks, at a titer of 10
12 pfu ml
1, were
maintained in Lambda-buffer at 4C.
Preparation of Plant Extract
Date fruits were obtained from a local date market
in Abu Dhabi, United Arab Emirates. The pits were
manually separated from the flesh and were rinsed clear
of any flesh by water and dried for 18h in a drying
cabinet (Unitemp) at 40C, and stored at room tempera-
ture. The dried date pits of 100g were crushed and
extracted with acetone (1:1 ratio, weight to volume)
under agitation at room temperature. After 48h, the
extract was then filtered through Whatman No. 2 filter
paper (Whatman International Limited, Kent, England)
and the filtrate was evaporated to dryness in a drying
cabinet (Unitemp) at 40C, and stored in a desiccator at
room temperature. The bioactive date pit extract was
found to be stable at room temperature for many
months. The yield of the extract was approximately
30% of the weight of the date pits.
Determination of Minimum Inhibitory Concentration
(MIC) Values
The MIC of the test date pit extract was determined for
test Pseudomonas phage ATCC 14209-B1 as follows:
Sterile Eppendorf micro-centrifuge tubes (polypropylene;
1.5ml; Sarstedt) were used for this purpose. Each tube
contained 110
4 colony-forming units (CFU) ml
1of
Ps. aeruginosa ATCC 25668 cultures, 1.510
7 PFU ml
1
of test Pseudomonas phage ATCC 14209-B1, serially
diluted date pit extract in LB (1, 10, 100 and
1000mgml
1), and respective growth medium (LB).
Triplicate samples were performed for each test concen-
tration. The controls included: (1) bacterial host cell
growth medium with serially diluted date pit extract; and
(2) inoculated phage and bacterial host cell growth
medium without the date pit extract. Sample blanks
contained uninoculated medium only. All tubes were
incubated at 37C and bacterial growth was estimated
spectrophotometrically (OD 600nm) after 18h using a
Spectrometer (Beckman DU 520). The MIC for test
phage was defined as the minimum concentration of test
date pit extract that reduced the host cell turbidity by
0.2 absorbance at 600nm.
Phage Inactivation Assays
The phage inactivation was determined using a previously
described protocol (24). One hundred microlitres of
Ps. aeruginosa ATCC 25668 culture of OD600nm=0.8
was added to 900ml of LB (control) and LB supple-
mented with either 1000 or 100mgml
1 of date pit extract
to give a final concentration of approximately 110
6
CFU ml
1 in sterile Eppendorf micro-centrifuge tubes,
and incubated on ice for 15min. The suspensions were
centrifuged for 10min at 5000g. The supernatant was
discarded, each pellet was resuspended in 1ml of
Lambda-buffer, and the initial cell count was determined
by measuring cfu on LA (25). Ten microliters of a
solution containing 110
11 PFU ml
1 of Pseudomonas
phage ATCC 14209-B1 was immediately added to give
a final multiplicity of infection of 1 CFU to 3 PFU. The
suspension was mixed thoroughly. After 5min incubation
at 37C, the number of surviving bacteria was evaluated
by 10-fold serial dilution in PBS and plating on LA
plates. The data were expressed as the CFU ml
1
Ps. aeruginosa ATCC 25668 enumerated after incubation
with Pseudomonas phage ATCC 14209-B1 divided by the
CFU ml
1 enumerated immediately prior to the addition
of phage, multiplied by 100. Each assay was replicated
three times.
Determination of Phage and Bacterial Inhibition Kinetics
Assays to determine the phage and bacterial inhibition
kinetics described by Stewart et al. (26) were used,
modified as follows (in brief): Pseudomonas phage ATCC
14209-B1 (10mla t7 10
9 pfu ml
1)o r1 0 mlo f
Ps. aeruginosa ATCC 25668 cultures (110
9 cfu ml
1)
were placed in a sterile Eppendorf micro-centrifuge tube
and 100ml of the date pit extract solution prepared in
sterile distilled water (10, 100 and 1000mgml
1), or 100ml
distilled water (as the control), were added. The suspen-
sions were mixed thoroughly. After exposure of phage or
bacteria for 1, 5, 15, 30 and 60min at room temperature,
the numbers of phage or bacteria surviving the above
protocol were measured by enumerating the pfu or cfu
counts, respectively. All determinations were performed
in triplicates.
The calculation of the decimal reduction time (D-value)
and the value of the concentration exponent (Z) were
calculated, as described by Bloomfield (27).
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Experiments were performed in triplicate. Bacteriophage
titrations and assays were performed in triplicate. The
arithmetic meanstandard error of the mean (SEM) of
control and experimental results were calculated using the
Student’s t-test. P<0.05 was considered statistically
significant.
Results
MIC
The acetone extract from pits of Phoenix dactylifera
L date demonstrated antiviral activity with an MIC
value of < 10mgml
1 for the Pseudomonas phage ATCC
14209-B1 tested (Fig. 1). The MIC activity of date pit
extract against the test phage was abolished after heat
treatment at 100C for 5min (data not shown).
Inhibitory Activities of Date Pit Extract
on Phage Lytic Properties
The phage lytic inhibitory properties in LB control and
the date pit extract of 10, 100 and 1000mgm1
1 were
evaluated from the date pit MIC assay, a similar pattern
was observed: 0, 61, 83 and 90%, respectively (Fig. 2).
The Kinetics of the Date Pit Extract on
the Phage Infectivity
To further understand the nature of this inhibition,
a series of experiments was performed to evaluate the
kinetics of the date pit extract on the phage infectivity.
This assay measured the rate of phage inhibition by
determination of the proportion of Ps. aeruginosa which
survived exposure to phage ATCC 14209-B1at a set
duration and concentration of date pit extract. Under the
conditions used, the mean bacterial survival rate of
Ps. aeruginosa which were exposed to LB control, as
compared to 100 and 1000mgm l
1 of date pit extract for
15min were 30, 50 and 100%, respectively (Fig. 3). The
differences in phage-binding activity between samples
treated with date pit extract and those treated with
control extract were statistically significant (P<0.001).
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Figure 1. The minimum inhibitory concentrations of date pit extract
and LB (‘L-broth’) control against Pseudomonas phage ATCC
14209-B1. A higher number of surviving bacteria reflects the increased
inhibitory activity (against the phages) of the higher concentrations of
date pit extract.
0
10
20
30
40
50
60
70
80
90
100
Concentration (µg ml−1)
%
 
B
a
c
t
e
r
i
a
 
s
u
r
v
i
v
i
n
g
 
a
t
 
1
8
h
 
L-Broth 1
10
100
1000
Figure 2. Inhibitory effect of date pit extract 1, 10, 100 and
1000mgml
1 and L-broth control on the ability of Pseudomonas
phage ATCC 14209-B1 to lyse, and thereby eliminate the growth of,
Pseudomonas aeruginosa ATCC 25668. Numbers are expressed as the
percentage of bacteria remaining after 18h incubation with
Pseudomonas phage ATCC 14209-B1. A higher number of surviving
bacteria reflects the increased inhibitory activity (against the phages) of
the higher concentrations of date pit extract.
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Figure 3. Inhibition of Pseudomonas phage ATCC 14209-B1 infectivity
to Pseudomonas aeruginosa ATCC 25668 brought about by 100 and
1000mgml
1 concentrations of date pit extract, versus L-broth control.
Numbers are expressed as the percentage of bacteria remaining after
5min incubation with Pseudomonas phage ATCC 14209-B1. Error bars
indicate SD. A high number of surviving bacteria indicates poor phage
infectivity.
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The time course (survivor curves) showing the virucidal
action of date pit extract was prepared by enumerating
the PFUs, with titers measured at appropriate intervals
(Fig. 4). With 1min of contact, the 1000mgm1
1 dose of
date pit extract brought about an 8-log reduction in
phage titers, which effectively eradicated all phage
activity by bringing the titers down to the range of the
limits of detection. For the next lower dose, that being
100mgm1
1 of date pit extract, with 1min of contact an
approximate 4 log reduction was achieved, and by 30min
of contact the titers had dropped another 3 logs, for
a total 7-log drop in titers.
Phage Inhibition Kinetic
The kinetics of inactivation can be described by means of
the decimal reduction time (D-value). This is defined as
the time taken at a fixed biocide concentration to achieve
a 1 log cycle reduction in survivors curve (i.e. its slope)
and can be determined from a time vs. log survivors
curve such as those in Fig. 4. D-values were determined,
for 100 and 1000mgm1
1 date pit extract, to be 2.36 and
0.25, respectively. From this, the concentration exponent
(Z) for date pit extract was determined, with an average
value of 0.954.
Discussion
This study was primarily designed to evaluate the anti-
viral efficacy of an acetone extract of the pits of the date
palm Phoenix dactylifera L against Pseudomonas phage
ATCC 14209-B1 (known to be relatively resistant to
disinfection) (28). Bacteriophages have been previously
studied to obtain information about mechanisms of
virucidal action (28–31).
The study is the first that we know of to reveal that
date pit extract has promising antiviral activity, with
MIC concentrations found to be > 10mgml
1 for
Pseudomonas phage ATCC 14209-B1 (Fig. 1).
It was also found that the 100 and 1000mgml
1
concentrations of date pit extract show a strong ability to
inhibit the infectivity of Pseudomonas phage ATCC 14209-
B1, as evidenced by the presence of higher numbers of
Ps. aeruginosa cells surviving (Fig. 2). The results suggest
that the cause of the inhibition could be due to interference
with some aspect of the phage’s lytic cycle. The lytic cycle
of the phage consists of three major phases (26): binding
to a suitable host bacterium and injection of its genome;
a period of intracellular production of new virions; and
then lysis of the cell and release of progeny phage into the
environment. To further understand the mechanism by
which Ps. aeruginosa cells resisted phage lysis in the
presence of date pit extract, the first of these stages,
phage binding, was investigated. This effect was shown to
be due to a direct effect of the extract on the phage itself
rather than an effect on the host cell.
It was found that the 100mgml
1 of date pit extract
strongly inhibited the infectivity of Pseudomonas phage
ATCC 14209-B1 to Ps. aeruginosa (Fig. 3), and that
this effect was abolished by heating (data not shown).
The phage infectivity inhibition may be attributable to
date pit extract’s heat-labile bioactive component(s)
attaching to or modifying the surface of the phages.
The bioactive component(s), namely, protein and some
derived polyphenolic compounds such as polysaccharides,
lignans and bioflavonoids, are present in reasonable
amounts in date pit (8,32), which were reported to act
principally by binding to the protein coat and thus arrest
absorption of the virus (3). However, further studies are
needed to investigate the direct effect of date pit protein
and polyphenolic compounds on phage binding to host
cells, and to determine whether the nucleic acid was
damaged inside the phage capsid.
The time course of the survivor curves (Fig. 4) of
concentrations of 100 and 1000mgml
1 of date pit extract
showed respective 4 to 8 log10 reductions in the bacterial
CFUs, within 1min, with D-values of 2.36 and 0.25,
respectively. These results were somewhat similar to
those reported for extracts of pomegranate (Punica
granatum L.) rind, Viburnum plicatum (leaves or flowers),
Camellia sinensis (tea leaves) or Acer pseudoplatanus
(maple leaves) (26,28). From the above the concentration
exponent was derived, with an average value of=0.954.
Similar concentration exponents were reported for
formaldehyde, quaternary ammonium and mercury
compounds in the range of 1 (27).
The pits of date palm (Phoenix dactylifera L.) are an
inexpensive component found in abundance in the
Middle East. In this study, date palm pit extract has
demonstrated positive antiviral results (this effect
was rapid, dose dependent, and appeared to be related
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Figure 4. The effect of contact time and concentration of date pit
extract on the viability of Pseudomonas phage ATCC 14209-B1.
Date pit extract concentrations (mgml
1) in L-broth: (filled triangle)
0; (open triangle) 10; (filled squares) 100; (open squares) 1000.
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and it seems reasonable to conclude that a further phyto-
chemical characterization of the active ingredients may
reveal useful compounds, and may also provide the basis
for further refinement of antiviral drug design and
development as potential biotherapeutic agents against
medically-important viruses, such as the human immuno-
deficiency virus (HIV). Since HIV is an RNA virus it is
not subjected to the ‘proofreading’ that occurs during
DNA transcription. As a consequence this kind of virus
mutates very often. This enables HIV to grow resistant
to antiretroviral pharmaceuticals quickly, and is one of
the main reasons why an effective vaccine for HIV has
not been developed yet (6).
In this regard, date palm pit extract could play an
important role in a control replication of HIV-1 this
hypothesis has been based from the results of date pit
extract which has strongly inhibited the infectivity of the
lytic Pseudomonas phage ATCC 14209-B1 to Ps. aerugi-
nosa as a result of novel mechanism of interaction with
binding of the phage to the host bacterium and injection
of its genome. Therefore, it could conceivably play a role
in combination therapy or even as a novel new class of
anti-HIV phyto chemo-type therapy for drugs develop-
ment ‘fusion and attachment inhibitors’ similar to the
Enfuvirtide (T-20) in which inhibit or blocks HIV from
entering the CD4 cell are important drugs for the
treatment of AIDS (6). Thus, further studies are needed
to elucidate the mechanism(s) of our findings and, of
equal importance, proceed to address further testing with
the HIV.
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